ロード中...
Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms
Beta-lactam/beta-lactamase inhibitor combination antimicrobials (BLBLIs) are among the most controversial classes of antibiotic agents available for the treatment of infections caused by extended-spectrum-beta-lactamase (ESBL)-producing Gram-negative bacteria (ESBL-GNR). Piperacillin-tazobactam (PTZ...
保存先:
| 出版年: | J Clin Microbiol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5824049/ https://ncbi.nlm.nih.gov/pubmed/29237787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01917-17 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|